Skip to main content
HLB Life Science CO.,LTD. logo

HLB Life Science CO.,LTD. — Investor Relations & Filings

Ticker · 067630 ISIN · KR7067630004 LEI · 9884006PTFB20S9PS149 KO Manufacturing
Filings indexed 396 across all filing types
Latest filing 2024-07-08 Capital/Financing Update
Country KR South Korea
Listing KO 067630

About HLB Life Science CO.,LTD.

https://www.hlb-lsmc.com/

HLB Life Science is a specialized pharmaceutical and biotechnology firm focused on the development of innovative anti-cancer medications and the manufacturing of medical devices. The company's research and development efforts center on targeted therapies and cell therapies for oncology. In parallel, it develops, manufactures, and distributes in vitro diagnostic (IVD) medical devices and quasi-drugs. The company's portfolio also includes the clinical development of anti-cancer drugs for animals, aiming to provide comprehensive solutions across human and animal health.

Recent filings

Filing Released Lang Actions
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from HLB Life Science regarding the 'Adjustment of Conversion Price' (전환가액의 조정) for its 11th series convertible bonds. It details the change in conversion price due to market price fluctuations, the impact on the number of convertible shares, and the legal basis for the adjustment. This type of disclosure relates to the company's capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2024-07-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider holdings and changes in ownership, which falls under the 'Director's Dealing' category (DIRS) in the provided schema, as it details share ownership changes by a major shareholder (HLB Co., Ltd.) in the issuing company (HLB Life Science).
2024-06-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (HLB Co., Ltd.) in HLB Life Science Co., Ltd. due to capital changes (rights offering and exercise price adjustments). This falls under the category of Major Shareholding Notification.
2024-06-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in South Korea. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal shareholdings and changes therein. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2024-06-28 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (capital increase via rights offering) by HLB Life Science. It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2024-06-24 Korean
증권발행실적보고서
Capital/Financing Update Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a capital increase (rights offering), including subscription dates, allocation results, and the use of proceeds. This type of filing is a standard regulatory requirement following a capital raise and falls under the category of capital/financing updates.
2024-06-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.